öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÀîÆé
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º227

ËùÊôԺУ£ºº£ÄÏҽѧԺ
ËùÊôԺϵ£ºÁÙ´²Ñ§Ôº
Ö°³Æ£º
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º¸¾²ú¿Æѧ
Ñо¿ÁìÓò£º ¸Éϸ°û¡¢¸¾²ú¿ÆÖ×Áö
Ñо¿ÁìÓò£º ¸Éϸ°û¡¢¸¾²ú¿ÆÖ×Áö [ÊÕÆð]




ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£º**@qq.com


¸öÈ˼òÊö :
¹¤×÷¾­Àú£º
1991.7-2005.12 ÖйúÈËÃñ½â·Å¾ü¹ú·À¿Æ¼¼´óѧ¸½ÊôÒ½Ôº Ö÷¹Ü¼¼Ê¦
2005.6-2010.12 º£ÄÏҽѧԺ ½²Ê¦ Ö÷¹Ü¼¼Ê¦
2010.1-ÖÁ½ñ º£ÄÏҽѧԺ¿ÆÑд¦ ¸±´¦³¤
2010.12-2013.1º£ÄÏҽѧԺ ¸±Ö÷Èμ¼Ê¦
2013.1-2014.12 º£ÄÏҽѧԺ ¸±Ñо¿Ô±
2014.12-ÖÁ½ñ º£ÄÏҽѧԺ Ñо¿Ô±
2006.8-2009.9 ÃÀ¹úµÂÖÝA&M´óѧÉúÃü¿ÆѧԺ ·ÃÎÊѧÕß
Ñо¿Éúµ¼Ê¦£º
2013.12-ÖÁ½ñ º£ÄÏҽѧԺÁÙ´²Ñ§Ôº ˶ʿÉúµ¼Ê¦
Ö÷½²¿Î³Ì£ºÉúÖ³ÓëÒÅ´«¡¢öλÔÓéÀֵǼÈë¿ÚÏÂÔØÓ¢Óï

¿ÆÑй¤×÷ :
·¢±íÎÄÕÂ
µÚÒ»×÷Õß·¢±íÎÄÕ£¨º¬Í¨Ñ¶×÷Õߣ©11ƪ£º
1¡¢ÀîÆ飬ÑîÏéʤ£¬ÖÜÏþ»ª£¬Ð¤Â¶£¬ÁÖêØ£¬Õŷ粨£¬ÀîÁáÀö£¬ÓàÑ޺죬ÂíÑàÁÕ.microRNA-133aÞ׿¹Ðļ¡·Ê´ó×÷ÓûúÖÆ.ÄÏ·½Ò½¿Æ´óѧѧ±¨.2015.09. ÍøÂçÓÅÏȳö°æ£¬2015-08-08 11:51:59.
2¡¢ÀîÆ飬ÖÜôí£¬ÂíÄþ£¬³ÂÑ©Òø£¬½ðӦϼ£¬³Âºê½¡£¬ÂíÑàÁÕ. Ó¦ÓÃÓ«¹â±ê¼ÇÒýÎï½øÐÐDMD¼ÒϵÁ¬Ëø·ÖÎö. Öйú¸¾Ó×±£½¡. 2015£¬30£¨21£©£º3659-3661.
3¡¢ÀîÆé¡¢ÖÜôí¡¢ÂíÄþµÈ¡£ÖйúÄÏ·½µØÇø²»ÓýÄÐÐÔYȾɫÌåAZFÇøÓò΢ȱʧ·ÖÎö¡£º£ÄÏҽѧ£¬2014£¬25£¨18£©£º2656-2659£¨µÚÒ»×÷Õߣ©
4¡¢Xing Zhao,QiLi,Wei-Min Jiang,Hong-Yan Liu,Ning Ma,Zhi Zhou,Lin-Jiang Li,Yuan-Hua Huang,Yan-Lin Ma. Expression level of pluripotent genes in incomplete reprogramming. ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE£¬2014,1.7(8):639-644£¨¹²µÚÒ»×÷Õߣ©¡£
5¡¢Qi Li, Junli Guo, Xi Lin, Xiangsheng Yang, Yanlin Ma, et al. An Intragenic SRF-Dependent Regulatory Motif Directs Cardiac-Specific microRNA-1-1/133a-2 Expression. PLos one, 2013,8(9):1-8,e77470£¨µÚÒ»×÷Õߣ©
6¡¢Xiangsheng Yang, Qi Li, Xi Lin£¬Yanlin Ma£¬et al. Mechanism of fibrotic cardiomyopathy in mice expressing truncated Rho-associated coiled-coil protein kinase 1. The FASEB Journal£¬2012,26£¨ 5£©:2105-2116 .(¹²µÚÒ»×÷Õß)¡£
7¡¢ÂíÑàÁÕ£¬ ÑîÏéʤ£¬ÁÖêØ£¬»ÆÔª»ª£¬ÀîÆé¡£ ÌݶÈÀëÐÄ·¨·ÖÀë¡¢¸»¼¯¡¢´¿»¯ÐÂÉúÈéÊóÐļ¡Ï¸°û¡£º£ÄÏҽѧԺѧ±¨ 2011,17£¨12£©£º1598-1605£¨Í¨Ñ¶×÷Õߣ©¡£
8¡¢ Qi Li. Xi Lin. Xiangsheng Yang. J Chang. NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression. Am J Physiol- Heart and Circ Physiol, 2010,298: H1340-H1347
9¡¢ÀîÆ飬ǮÎÀƽ£¬×ÞºìÑ޵ȡ£148 Àý²»Ôв»Óý¸¾Å®TORCH ¿¹Ìå¼ì²â¡£Öйú¸¾Ó×±£½¡ÔÓÖ¾£¬2005,20(10):1267-1269
10¡¢ ÀîÆé, ÂíÑàÁÕ, ÅËǬ, µÈ¡£Ï¸°ûÁѽⷨ¶ÔÖ²ÈëÇ°Õï¶ÏÖоۺÏøÁ´·´Ó¦À©ÔöЧÂʵÄÓ°Ïì¡£ºþÄÏÒ½¿Æ´óѧѧ±¨£¬2002,27(3):189-191¡£
11¡¢ÀîÆé, ÂíÑàÁÕ, ÅËǬ, µÈ¡£Ó¦ÓþۺÏøÁ´Ê½·´Ó¦-øÇз¨½øÐм¹ËèÐÔ¼¡Î®ËõµÄ»ùÒòÕï¶Ï¼°²úÇ°Õï¶Ï¡£ÖлªÒ½Ñ§£¬2001,81:447-1449
·ÇµÚÒ»×÷Õß·¢±íÎÄÕ£¨21ƪ£©
1¡¢°×Ãô£¬ÀîÆ飬ÉÛÑÞ毣¬»ÆÔª»ª£¬Àî´óÁ¦£¬ÂíÑàÁÕ. ÀûÓÃCRISPR/Cas9¼¼Êõ¹¹½¨¶¨µãÍ»±äСÊóƷϵ.ÒÅ´«.ÍøÂçÓÅÏȳö°æ£¬2015-08-12 09:06:31.
2¡¢½¯Î°Ãñ¡¢ÕÔÐÇ¡¢ÀîÆéµÈ¡£Á½ÖÖÅàÑøÌõ¼þÏÂÈËÅßÌ¥¸Éϸ°ûÉú³¤×´¿öϵıȽÏ¡£º£ÄÏҽѧԺѧ±¨£¬2013£¬9£¨19£©£º1175-1179.
3¡¢Xi Lin, Xiangsheng Yang, Qi Li, Yanlin Ma, et.al. Protein Tyrosine Phosphatase-Like A Regulates Myoblast Proliferation and Differentiation through MyoG and the Cell Cycling Signaling Pathway. Molecular and cell biology,2012,32(2):297-308
4¡¢Viraj R. Shah,1 Maranke I. Koster,Qi Li et al.Double-Inducible Gene Activation Systemfor Caspase 3 and 9 in Epidermis. Genesis 2007 45:194-199.
5¡¢Yanlin Ma, Baicheng Gong, Jiahui Xia, Liqi,et al. Han Chinese population data for tenSTR loci in Changsha, China. Journal of Forensic Sciences, 2002, 47: 404-405
6¡¢Tang BS, Luo W, Zhao GH, Xiao Jf, Li Qi, Ma YL, Xia K and Yang QD. Cx32 gene mutation associated with X-linked recessive Charcot-Marie-Tooth disease. Progress in naturalscience, 2003, 13(5): 475-477.
7¡¢ÂíÄþ£¬½ðӦϼ£¬»ÆÔª»ª£¬ÀîÆéµÈ¡£º£ÄϵØÇøÒ»ÀýNSHL»¼ÕßµÄCx26»ùÒòÍ»±ä·ÖÎö ÖйúÈÈ´øҽѧ,2010,(10)8£º949-951
8¡¢Ã«¼ÇÁú,½ðӦϼ,ÂíÄþ,³ÂÑ©Òø,ÂóÑîÇà,³Â¾¹Î÷,Íõ÷ºì,ÀèÃ÷ºì,»ÆÔª»ª,Ðìö©,¬ΰӢ,ÀîÆéµÈ¡£º£ÄϵØÇø718ÀýÄÐÐÔ²»Óý»¼ÕßAZF»ùÒò΢ȱʧÑо¿¡£ÖйúÈÈ´øҽѧ£¬2010,(10)7:845,854
9¡¢³ÂÑ©Òø£¬½ðӦϼ£¬ÀîÈ»»¨£¬ÀîÆéµÈ¡£Ì¥¶ùÒÅ´«²¡ÊµÑéÕï¶Ï±ê±¾²É¼¯·½·¨µÄ¶Ô±È·ÖÎö¡£ÖйúÈÈ´øҽѧ ,2006(6)10:1841-1842
10¡¢³ÂÑ©Òø£¬ÀîÆéµÈ¡£30ÀýÑÏÖØÉÙ¾«Ö¢¡¢ÎÞ¾«×ÓÖ¢»¼ÕßµÄÒÅ´«Ñ§·ÖÎö¡£ÖйúÈÈ´øҽѧ ,2006,(6)9:1736-1737
11¡¢ÂíÑàÁÕ£¬ÀîÆ飬»ÆÔª»ª¡£¼¡ÓªÑø²»Á¼µÄ·Ö×ÓÒÅ´«Ñ§½øÕ¹¡£ÖйúÈÈ´øҽѧ ,2006,(6)1:165-167
12¡¢Ç®ÎÀƽ£¬ÀîÆéµÈ¡£ÐÔÁ¬ËøÒÅ´«²¡Ö²ÈëÇ°Õï¶ÏµÄÁÙ´²Ç°ÔËÓÃÑо¿¡£ÊµÓÃÔ¤·Àҽѧ£¬2005,(12)5 :1046-1048
13¡¢·ëÓÀ£¬ºØ³þ·å£¬ÏÄÀ¥£¬ÀîÆéµÈ¡£CX31.1»ùÒòÔÚÒÅ´«ÐÔÁû¼ÒϵÖеÄÍ»±ä·ÖÎö¡£ÁÙ´²¶ú±ÇÑʺí¿ÆÔÓÖ¾,2005,(119)4:178-179
14¡¢ Ç®ÎÀƽ£¬ÀîÆéµÈ¡£ÉÙ¾«Ö¢»¼ÕßYȾɫÌå΢ȱʧ»ùÒòÕï¶ÏµÄÑо¿¡£ÊµÓÃÔ¤·Àҽѧ£¬2005,(12)3:566-568
15¡¢Íõ±ù£¬ºú¶¬ì㣬ÏļһÔ£¬ÀîÆéµÈ¡£FBN1 mutation in Chinese patients with Marfan syndrome and its gene diagnoses using haplotype linkage analysis¡£ÖлªÒ½Ñ§ÔÓÖ¾£¨Ó¢Îİ棩£¬2003,116(7) : 1043-1046
16¡¢·ëÓÀ,ºØ¶¨»ª,ÏÄÀ¥,ÀîÆéµÈ¡£¶ÔÒ»¸öеĶúÁûºòÑ¡»ùÒò-TECTBµÄ³õ²½Ñо¿¡£Öйú¶ú±ÇÑʺí­µ×Íâ¿ÆÔÓÖ¾£¬2003,9(6):338-340
17¡¢ÂÞΡ£¬ÌƱ±É³£¬ÕÔ¹ú»ª£¬ÀîÆéµÈ¡£Éñ¾­Ë¿ÇáÁ´»ùÒòÔÚëè¹Ç¼¡Î®ËõÖ¢ÖеÄÍ»±ä·ÖÎö¡£ÖлªÒ½Ñ§ÒÅ´«Ñ§ÔÓÖ¾,2003,(20)2:169-170
18¡¢ÎÄÊÚùÁáǪ£¬ÀîÆéµÈ¡£Ó«¹â¶àÖØPCR¶Ô¦ÁµØÖк£Æ¶ÑªµÄ»ùÒòÕï¶Ï¡£ºþÄÏÒ½¿Æ´óѧѧ±¨,2003£¨28£©2£º123-126
19¡¢Íõ±ù£¬ºú¶¬ì㣬ÏļһÔ£¬ÀîÆéµÈ¡£Âí·²×ÛºÏÕ÷΢ÏËάµ°°×Ô­1 »ùÒòÍ»±ä¼ì²â¼°µ¥±¶ÐÍÁ¬Ëø·ÖÎö¡£ÖлªÒ½Ñ§ÒÅ´«Ñ§ÔÓÖ¾,2003,20(1):1-4
20¡¢ÂíÑàÁÕ, ÀîÆéµÈ¡£ÔËÓõ¥Ï¸°û¾ÛºÏøÁ´Ê½·´Ó¦½øÐÐÖ²ÈëÇ°Õï¶ÏµÄÐÔ±ð¼ø¶¨¡£ºþÄÏÒ½¿Æ´óѧѧ±¨£¬2002,27(6):487-490
21¡¢ÂÞΡ,ÌƱ±É³,Ïô½£·æ,ÀîÆéµÈ¡£X-Á¬ËøÒþÐÔÒÅ´«µÄëè¹Ç¼¡Î®ËõÖ¢ÓëCx32 »ùÒòÍ»±ä.ÖлªÄÚ¿ÆÔÓÖ¾,2001,40(8):543-5457.
³ö°æרÖø£¨2²¿£©£º
1¡¢¡¶ÉúֳҽѧÓëÒÅ´«¡·£¬º£Äϳö°æÉ磬2011Äê6Ô³ö°æ£¬ISBN 978-7-5443-3601-7.£¨¸±Ö÷±à£©
2¡¢¡¶ÁÙ´²·Ö×ÓÕï¶Ï¼¼Êõ¡·£¬º£Äϳö°æÉ磬2014Äê9Ô³ö°æ£¬ISBN 978-7-5443-5672-5.£¨Ö÷±à£©


½ÌÓý±³¾° :
1991.7±ÏÒµÓÚºþÄÏҽѧ¸ßµÈר¿ÆѧУ£¬Ò½Ñ§¼ìÑéöλÔÓéÀֵǼÈë¿ÚÏÂÔØ
1999.9-2002.9 ÖÐÄÏ´óѧҽѧÒÅ´«Ñ§¹ú¼ÒÖصãʵÑéÊÒ£¬Ò½Ñ§ÒÅ´«Ñ§öλÔÓéÀֵǼÈë¿ÚÏÂÔØ